Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Enteropathy-associated T-cell lymphoma: molecular clonal evolution and its clinical consequences.

Haematologica·2026
Same author

Nodular lymphocyte-predominant Hodgkin lymphoma controversy and insights: a global NLPHL one working group summit report.

Leukemia·2026
Same author

Risk of autoimmune and rheumatic diseases in breast cancer patients with silicone breast implants.

Journal of the National Cancer Institute·2026
Same author

Lenalidomide-rituximab or lenalidomide-rituximab-bendamustine for relapsed/refractory follicular lymphoma: primary and final analysis of the randomized phase II HOVON110/ReBeL study.

Haematologica·2026
Same author

A comparison of Breast Implant Illness-related symptoms between breast cancer survivors and breast augmentation recipients.

Plastic and reconstructive surgery·2026
Same author

Different primary thyroid B-cell lymphomas show overlapping mutation profiles, suggesting involvement of a common pathogenic process.

Haematologica·2026

Related Experiment Video

Updated: Jun 24, 2026

Isolating Malignant and Non-Malignant B Cells from lck:eGFP Zebrafish
08:32

Isolating Malignant and Non-Malignant B Cells from lck:eGFP Zebrafish

Published on: February 22, 2019

Translocation t(11;18)(q21;q21) in gastric B-cell lymphomas.

Sonia Toracchio1, Hiroyoshi Ota, Daphne de Jong

  • 1Department of Medicine, Section of Gastroenterology, Baylor College of Medicine, and Michael E. DeBakey Veterans Affairs Medical Center, Houston, Texas, USA. toracchi@bcm.tmc.edu

Cancer Science
|March 27, 2009
PubMed
Summary

The t(11;18) translocation is found in both gastric MALT lymphoma and diffuse large B-cell lymphoma at similar rates. This finding suggests that the presence of t(11;18) does not prevent progression to diffuse large B-cell lymphoma.

More Related Videos

Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down
08:59

Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down

Published on: December 11, 2017

Related Experiment Videos

Last Updated: Jun 24, 2026

Isolating Malignant and Non-Malignant B Cells from lck:eGFP Zebrafish
08:32

Isolating Malignant and Non-Malignant B Cells from lck:eGFP Zebrafish

Published on: February 22, 2019

Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down
08:59

Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down

Published on: December 11, 2017

Area of Science:

  • Oncology
  • Genetics
  • Pathology

Background:

  • The t(11;18)(q21;q21) translocation is the most common chromosomal abnormality in gastric mucosa-associated lymphoid tissue (MALT) lymphomas.
  • This translocation is rarely found in diffuse large B-cell lymphomas (DLBCL), leading to the hypothesis that t(11;18)-positive tumors seldom progress to DLBCL.

Purpose of the Study:

  • To investigate the frequency of the t(11;18)(q21;q21) translocation in gastric MALT lymphoma and DLBCL.
  • To determine if the presence of t(11;18) influences the progression of gastric lymphomas.

Main Methods:

  • Retrospective analysis of 53 gastric B-cell lymphoma cases (33 DLBCL, 20 MALT).
  • Detection of t(11;18)(q21;q21) using reverse transcriptase-polymerase chain reaction and/or fluorescence in situ hybridization.
  • Beta-actin transcript analysis to ensure RNA integrity from paraffin-embedded tissues.

Main Results:

  • The t(11;18) translocation was detected in 19% of DLBCL cases and 26% of MALT lymphoma cases.
  • The frequency of the translocation was not significantly different between the two lymphoma types (P = 0.72).
  • One DLBCL case with a MALT component also showed the t(11;18) translocation.

Conclusions:

  • The t(11;18)(q21;q21) translocation occurs with similar frequencies in both gastric MALT lymphoma and DLBCL.
  • The presence of the t(11;18) translocation does not preclude the progression of gastric lymphomas to DLBCL.